ALLOX
PrivateLast Round
Seed
Oct 29, 2026
Total Funding Raised
$10.6M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
ALLOX operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a Seed round in October 2026.
ALLOX is a biotechnology company that operates an AI-powered drug discovery platform to treat human diseases by designing new drugs targeting allosteric sites.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ALLOX Comparables
Compare ALLOX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adoram Therapeutics | 79% | |
| Nutshell Therapeutics | 79% | |
| Atavistik Bio | 78% |
For institutional investors. Book with your work email.
ALLOX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 29, 2026 | ||||
| Grant | Oct 15, 2024 | ||||
| VC Round | Sep 11, 2024 | ||||
| Pre Seed | Nov 30, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ALLOX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | VC Round, Pre Seed, Seed |
| Center for Technological Development and Innovation | Seed, VC Round |
| Catalan Institute of Finance | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2026
$11M round led by Asabys Partners.
- Feb 11, 2026
Grew 44% QoQ, from 16 to 23 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresOct 29, 2026
ALLOX appoints Morten Graugaard, who brings more than 20 years of experience in life sciences venture investment, research and development, business development, mergers and acquisitions, and biotechnology company management.
- is_developingOct 29, 2026
ALLOX is developing a drug discovery platform that combines high-throughput genetics, experimental biology and artificial intelligence to identify unexplored opportunities for small-molecule therapeutics.
- is_developingOct 29, 2026
ALLOX uses proceeds from its seed financing to develop proprietary AI models that predict therapeutic hotspots from large, function-first biophysical datasets, supporting the discovery of selective allosteric modulators in Spain on Oct 29th '26.
- hiresOct 29, 2026
ALLOX appoints Morten Graugaard as Independent Chair of its Board to help scale its allosteric drug discovery platform and build its pipeline, alongside the closing of a $10.5 million seed financing in Spain on Oct 29th '26.
- receives_financingOct 29, 2026
ALLOX receives $10.5M Seed financing in Spain on Oct 29th '26, led by Asabys through its Sabadell Asabys II fund with participation from CDTI through SICC Innvierte and ICF, to scale its platform, develop AI models, strengthen its drug discovery team, and support strategic collaborations.
For institutional investors. Book with your work email.
ALLOX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ALLOX's valuation, stock price, and market status.
Is ALLOX a public or private company?
ALLOX is a private company.
What is the current stock price of ALLOX?
ALLOX is a private company, so its shares have no public market price. Caplight tracks ALLOX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ALLOX worth (valuation)?
Valuation information for ALLOX is not publicly available.
Can I buy ALLOX stock?
ALLOX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ALLOX's last funding round?
ALLOX's most recent funding round was Seed on October 29, 2026.
Who are the main investors in ALLOX?
Key investors in ALLOX include Asabys Partners.
Will ALLOX IPO soon?
No public IPO plans have been announced for ALLOX.
How can I track ALLOX secondary market activity?
Caplight tracks bids, offers, and trades in ALLOX's shares on secondary markets.